BioMarin Pharmaceutical Shares Down 10.6% Since SmarTrend's Sell Call (BMRN)

SmarTrend identified a Downtrend for BioMarin Pharmaceutical (NASDAQ:BMRN) on November 16th, 2015 at $105.83. In approximately 3 weeks, BioMarin Pharmaceutical has returned 10.58% as of today's recent price of...